Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice

Por Judge, Adam D., Robbins, Marjorie, Tavakoli, Iran, Levi, Jasna, Hu, Lina, Fronda, Anna, Ambegia, Ellen, McClintock, Kevin, MacLachlan, Ian
Publicado em 2009

Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain

Por Banuelos, Carmen A., Tavakoli, Iran, Tien, Amy H., Caley, Daniel P., Mawji, Nasrin R., Li, Zhenzhen, Wang, Jun, Yang, Yu Chi, Imamura, Yusuke, Yan, Luping, Wen, Jian Guo, Andersen, Raymond J., Sadar, Marianne D.
Publicado no J Biol Chem (2016)

An androgen receptor N-terminal domain antagonist for treating prostate cancer

Por Myung, Jae-Kyung, Banuelos, Carmen A., Fernandez, Javier Garcia, Mawji, Nasrin R., Wang, Jun, Tien, Amy H., Yang, Yu Chi, Tavakoli, Iran, Haile, Simon, Watt, Kate, McEwan, Iain J., Plymate, Stephen, Andersen, Raymond J., Sadar, Marianne D.
Publicado em 2013